Medicinal product name Tasigna
Pharmaceutical form Capsule, hard
Strength 200 mg 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.)
KZS NHS Reimbursed medicines
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code L01EA03 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N112: 4 × 28
(200 mg)
PVC/PVDC/Al blister 4504.27 
KZS*
EU/1/07/422/008  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/07/422/008
Date of authorisation May 24, 2011
Marketing authorisation holder, country Novartis Europharm Limited, Ireland